• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    2/12/25 2:55:55 PM ET
    $GOOS
    Apparel
    Consumer Discretionary
    Get the next $GOOS alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Canada Goose Holdings Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    135086106

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    135086106


    1Names of Reporting Persons

    Patient Capital Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    3,807,448.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    3,807,448.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    3,807,448.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.42 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    135086106


    1Names of Reporting Persons

    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,900,000.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,900,000.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,900,000.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.33 %
    12Type of Reporting Person (See Instructions)

    IV

    Comment for Type of Reporting Person:  1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,854,520 shares of common stock. 2) Patient Opportunity Trust is deemed to be beneficial owner of 2,900,000 shares of common stock.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Canada Goose Holdings Inc.
    (b)Address of issuer's principal executive offices:

    250 Bowie Ave. Toronto, ONTARIO, CANADA M6E 4Y2
    Item 2. 
    (a)Name of person filing:

    Patient Capital Management, LLC Patient Opportunity Trust, a series of Advisor Managed Portfolios
    (b)Address or principal business office or, if none, residence:

    ONE SOUTH STREET, SUITE 2550 BALTIMORE, Maryland 21202
    (c)Citizenship:

    Patient Capital Management, LLC - DELAWARE Patient Opportunity Trust, a series of Advisor Managed Portfolios - DELAWARE
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    135086106
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,807,448 shares of common stock. 2) Patient Opportunity Trust is deemed to be beneficial owner of 2,900,000 shares of common stock.
    (b)Percent of class:

    8.42  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Patient Capital Management, LLC - 3,807,448 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 2,900,000

     (ii) Shared power to vote or to direct the vote:

    Patient Capital Management, LLC - 0 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

     (iii) Sole power to dispose or to direct the disposition of:

    Patient Capital Management, LLC - 3,807,448 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 2,900,000

     (iv) Shared power to dispose or to direct the disposition of:

    Patient Capital Management, LLC - 0 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various accounts managed by Patient Capital Management, LLC have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. The interest of one account, Patient Opportunity Trust, a series of Advisor Managed Portfolios, an investment company registered under the Investment Company Act of 1940 and managed by Patient Capital Management, LLC was deemed to be the beneficial owner of 2,900,000 shares or 6.33% of the total shares outstanding as of December 31, 2024.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Patient Capital Management, LLC
     
    Signature:Milton Dodge
    Name/Title:Chief Compliance Officer
    Date:02/12/2025
     
    Patient Opportunity Trust, a series of Advisor Managed Portfolios
     
    Signature:Russell B. Simon
    Name/Title:President
    Date:02/12/2025
    Exhibit Information

    Exhibit A Joint Filing Agreement Patient Capital Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940) and Patient Opportunity Trust, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate.

    Get the next $GOOS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GOOS

    DatePrice TargetRatingAnalyst
    4/30/2025Underweight → Equal Weight
    Wells Fargo
    3/31/2025$10.00 → $8.00Equal Weight → Underweight
    Barclays
    10/21/2024$11.50 → $9.00Neutral → Sell
    Goldman
    10/14/2024Equal Weight → Underweight
    Wells Fargo
    7/23/2024Outperform → Mkt Perform
    Raymond James
    7/19/2024Outperform
    Wedbush
    11/7/2023$11.00In-line
    Evercore ISI
    10/19/2023Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $GOOS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE Content Advisory: Pre-Market update + Retailers report earnings

      NEW YORK, May 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on May 21st Stocks are moving lower early Wednesday after the S&P 500 snapped a six-day winning streak. It's a small pull back after what has been a fast recovery from April's lows.Traders are monitoring Washington D.C. for updated on the budget bill and federal deficit. The bill would push through President Donald Trump's agenda of tax cuts and border security.Reporting earnings this mornin

      5/21/25 8:55:00 AM ET
      $APG
      $GOOS
      $ICE
      $LOW
      Engineering & Construction
      Consumer Discretionary
      Apparel
      Investment Bankers/Brokers/Service
    • Canada Goose Reports Fourth Quarter and Full Year Fiscal 2025 Results

      Fourth Quarter Revenue increased 7% year-over-year to $384.6M Reported net income of $27.7M Adjusted EBIT1 of $59.7M Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the fourth quarter of fiscal 2025 and fiscal year ending March 30, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our strong Q4 results show the kind of impact Canada Goose can make when our brand connects and our strategy hits the mark," said Dani Reiss, Chairman and CEO, Canada Goose. "We saw solid DTC comparable sales growth, fuelled by compelling storytelling, sharp retail execution, and the continued momentum around our Snow Goose capsule. As we close out fiscal

      5/21/25 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on May 21, 2025

        Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) plans to announce results for the fourth quarter and fiscal year 2025, which ended March 30, 2025, before markets open on Wednesday, May 21, 2025. The Company will host a conference call and webcast to discuss fourth quarter and fiscal 2025 results at 8:30am ET on Wednesday, May 21, 2025. A live webcast of the conference call will be available on the company's website at http://investor.canadagoose.com. The conference call can be accessed by using the following link: Canada Goose Q4 2025 Earnings Call. After registering, an email including the conference call link will be sent to join the live call. An archived replay of the webcast will be

      5/1/25 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/14/24 12:31:28 PM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/12/24 11:54:03 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/6/24 5:31:25 PM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Financials

    Live finance-specific insights

    See more
    • Canada Goose Reports Fourth Quarter and Full Year Fiscal 2025 Results

      Fourth Quarter Revenue increased 7% year-over-year to $384.6M Reported net income of $27.7M Adjusted EBIT1 of $59.7M Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the fourth quarter of fiscal 2025 and fiscal year ending March 30, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our strong Q4 results show the kind of impact Canada Goose can make when our brand connects and our strategy hits the mark," said Dani Reiss, Chairman and CEO, Canada Goose. "We saw solid DTC comparable sales growth, fuelled by compelling storytelling, sharp retail execution, and the continued momentum around our Snow Goose capsule. As we close out fiscal

      5/21/25 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on May 21, 2025

        Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) plans to announce results for the fourth quarter and fiscal year 2025, which ended March 30, 2025, before markets open on Wednesday, May 21, 2025. The Company will host a conference call and webcast to discuss fourth quarter and fiscal 2025 results at 8:30am ET on Wednesday, May 21, 2025. A live webcast of the conference call will be available on the company's website at http://investor.canadagoose.com. The conference call can be accessed by using the following link: Canada Goose Q4 2025 Earnings Call. After registering, an email including the conference call link will be sent to join the live call. An archived replay of the webcast will be

      5/1/25 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Reports Third Quarter Fiscal 2025 Results

      Revenue of $607.9M Net income attributable to shareholders was $139.7m, or $1.42 per diluted share Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the third quarter of fiscal 2025, which ended December 29, 2024. All amounts are in Canadian dollars unless otherwise indicated. "Our third quarter results highlight the power of strong execution during a key consumer shopping period, particularly in December where we saw significant acceleration in the business," said Dani Reiss, Chairman and CEO of Canada Goose. "Brand momentum was robust in the quarter, amplified by the integrated global launch of our new Snow Goose collection which drove record-setting

      2/6/25 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    SEC Filings

    See more
    • SEC Form 6-K filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      6-K - Canada Goose Holdings Inc. (0001690511) (Filer)

      5/21/25 7:46:27 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • SEC Form 20-F filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      20-F - Canada Goose Holdings Inc. (0001690511) (Filer)

      5/21/25 7:40:32 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SCHEDULE 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      5/14/25 3:03:14 PM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Leadership Updates

    Live Leadership Updates

    See more

    $GOOS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canada Goose Strengthens Executive Team with SVP of Merchandising, Judit Bankus

      Luxury leader to drive long-term merchandising strategy Today, Canada Goose announced Judit Bankus as Senior Vice President of Merchandising. Judit will play a key role in shaping the brand's product roadmap through a lens of sustainability and innovation, to support the company's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128073823/en/Judit Bankus (Photo: Business Wire) Reporting to Carrie Baker, President, Brand & Commercial, Judit will oversee the development and execution of global merchandising and pricing strategies, guiding the expansion across both existing and emerging product categories. She

      1/28/25 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Welcomes Alfredo Cunanan Mendoza Tan as Chief Digital & Information Officer

      Alfredo will oversee all consumer-facing digital platforms, as well as IT, Digital Media & Marketing and Consumer Insights Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today Alfredo C. M. Tan as our new Chief Digital & Information Officer, effective August 7, 2024. Alfredo takes over for Matt Blonder who will be departing Canada Goose. As Chief Digital & Information Officer, Alfredo C. M. Tan will be responsible for the strategy, implementation and adoption of all consumer-facing digital platforms. He will drive the brand's digital capabilities and lead the teams responsible for developing the company's digital roadmap across digital sales channels, as well as the company's IT

      7/12/24 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Appoints Beth Clymer as President, Finance, Strategy & Administration

      Today, Canada Goose announced the appointment of Beth Clymer to the newly created position of President, Finance, Strategy & Administration, starting January 8, 2024. Beth will oversee Finance, People & Culture, Corporate Strategy and Legal, partnering with the talented leaders who drive these functions. Both Beth and Carrie Baker, President, Brand & Commercial will report to Dani Reiss, Chairman & CEO. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231220857533/en/(Photo: Business Wire) "Beth has a long history and depth of experience working with Canada Goose, having been a key partner of ours during her time at Bain Capital,

      12/20/23 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose upgraded by Wells Fargo

      Wells Fargo upgraded Canada Goose from Underweight to Equal Weight

      4/30/25 7:23:38 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose downgraded by Barclays with a new price target

      Barclays downgraded Canada Goose from Equal Weight to Underweight and set a new price target of $8.00 from $10.00 previously

      3/31/25 8:11:36 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose downgraded by Goldman with a new price target

      Goldman downgraded Canada Goose from Neutral to Sell and set a new price target of $9.00 from $11.50 previously

      10/21/24 7:42:11 AM ET
      $GOOS
      Apparel
      Consumer Discretionary